EGFR and HER2 hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer
| Autor: | Belli, Stefania, Esposito, Daniela, Ascione, Claudia M., Messina, Francesca, Napolitano, Fabiana, Servetto, Alberto, De Angelis, Carmine, Bianco, Roberto, Formisano, Luigi |
|---|---|
| Zdroj: | In Cancer Letters 1 July 2024 593 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect